Joel Clayborne Stephens, Ph.D., SVP and Chief Scientific Officer of Motif Biosciences, USA visited Sankara Nethralaya on 14-11-2007. He had discussions about possible collaboration with Vision Research Foundation on mapping disease genes for ophthalmic diseases. Motif Biosciences Inc. is a population genetics company seeking to identify the genetic causes of major diseases by working with a unique, rich, and defensible source of human genetic data from populations throughout the world. Previously, Mr. Stephens was Vice President of Genetics and Executive Director of Population Genomics at Genaissance Pharmaceuticals (NASDAQ: GNSC) in New Haven, CT. Prior to that, Clay had served as a Principal Investigator, Head of Bioinformatics Group, and a Senior Staff Fellow at the National Institute of Health, NCI, DBS Laboratory of Genomic Diversity.